Answers are grounded in this paper and cite their sources.
Retrospective study evaluates renal outcomes in IgA nephropathy patients receiving SGLT2 inhibitors, suggesting potential benefits over standard care.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Gutierrez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: